These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 4148434)

  • 21. Autoreceptor-mediated inhibition of 3H-5-hydroxytryptamine release from rat brain cortex slices by analogues of 5-hydroxytryptamine.
    Göthert M; Schlicker E
    Life Sci; 1983 Mar; 32(11):1183-91. PubMed ID: 6572776
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The urinary excretion of 5-hydroxyindoleacetic acid does not reflect brain levels of this metabolite of 5-hydroxytryptamine.
    Aizenstein ML; Scavone C
    Braz J Med Biol Res; 1984; 17(3-4):323-7. PubMed ID: 6085023
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of 5,7-dihydroxytryptamine on an identified 5-hydroxytryptamine-containing neurone in the central nervous sytem of the snail Helix pomatia.
    Osborne NN; Pentreath VW
    Br J Pharmacol; 1976 Jan; 56(1):29-38. PubMed ID: 1252663
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative studies of brain 5-hydroxytryptamine and tryptamine.
    Knott PJ; Marsden CA; Curzon G
    Adv Biochem Psychopharmacol; 1974; 11(0):109-14. PubMed ID: 4602667
    [No Abstract]   [Full Text] [Related]  

  • 25. An assay procedure for tryptamine in brain and spinal cord using its (3H)dansyl derivative.
    Snodgrass SR; Horn AS
    J Neurochem; 1973 Sep; 21(3):687-96. PubMed ID: 4147502
    [No Abstract]   [Full Text] [Related]  

  • 26. Binding of serotonin to soluble protein from synaptosomes.
    Tamir H; Huang YL
    Life Sci; 1974 Jan; 14(1):83-93. PubMed ID: 4810501
    [No Abstract]   [Full Text] [Related]  

  • 27. Potentiation and antagonism of biogenic amines.
    Rauzzino FJ; Seifter J
    J Pharmacol Exp Ther; 1967 Jul; 157(1):143-8. PubMed ID: 5298351
    [No Abstract]   [Full Text] [Related]  

  • 28. Identification of dopamine, noradrenaline and 5-hydroxytryptamine varicosities in a fraction containing nerve ending particles.
    Fuxe K; Grobecker H; Hökfelt T; Jonsson G
    Brain Res; 1967 Nov; 6(3):475-80. PubMed ID: 6076252
    [No Abstract]   [Full Text] [Related]  

  • 29. The effects of putative 5-hydroxytryptamine antagonists on the behaviour produced by administration of tranylcypromine and L-tryptophan or tranylcypromine and L-DOPA to rats.
    Deakin JF; Green AR
    Br J Pharmacol; 1978 Oct; 64(2):201-9. PubMed ID: 708990
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of central serotonin depletion on DOCA-saline hypertension in the rat.
    Myers MG; Reid JL; Lewis PJ
    Cardiovasc Res; 1974 Nov; 8(6):806-10. PubMed ID: 4457231
    [No Abstract]   [Full Text] [Related]  

  • 31. Accumulation of tritiated 5-hydroxytryptamine in brain slices.
    Ross SB; Renyl AL
    Life Sci; 1967 Jul; 6(13):1407-15. PubMed ID: 4382451
    [No Abstract]   [Full Text] [Related]  

  • 32. Axonal degeneration and regeneration of bulbo-spinal indolamine neurons after 5,6-dihydroxytryptamine treatment.
    Nobin A; Baumgarten HG; Björklund A; Lachenmayer L; Stenevi U
    Brain Res; 1973 Jun; 56():1-24. PubMed ID: 4715620
    [No Abstract]   [Full Text] [Related]  

  • 33. Tryptophan hydroxylase of the central nervous system: effect of intraventricular 5,6- and 5,7-dihydroxytryptamine.
    Lovenberg W; Victor SJ
    Adv Biochem Psychopharmacol; 1974; 10():93-101. PubMed ID: 4603031
    [No Abstract]   [Full Text] [Related]  

  • 34. Serotonin and catecholamine concentrations in brain of rats injected intracerebrally with 5,6-dihydroxytryptamine.
    Costa E; LeFevre H; Meek J; Revuelta A; Spano F; Strada S; Daly J
    Brain Res; 1972 Sep; 44(1):304-8. PubMed ID: 5056985
    [No Abstract]   [Full Text] [Related]  

  • 35. Behavioral and biochemical interactions of 5,7-dihydroxytryptamine with various drugs when administered intracisternally to adult and developing rats.
    Breese GR; Cooper BR
    Brain Res; 1975 Nov; 98(3):517-27. PubMed ID: 1242372
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regeneration of central serotonin neurons after axonal degeneration induced by 5,6-dihydroxytryptamine.
    Björklund A; Nobin A; Stenevi U
    Brain Res; 1973 Feb; 50(1):214-20. PubMed ID: 4690548
    [No Abstract]   [Full Text] [Related]  

  • 37. Regional distribution and metabolism of H3-tyramine in the rat brain.
    Goldstein M; Anagnoste B; Yamamoto A; Felch WC
    J Pharmacol Exp Ther; 1970 Feb; 171(2):196-204. PubMed ID: 4391786
    [No Abstract]   [Full Text] [Related]  

  • 38. Some aspects of the interrelationship between central 5-hydroxytryptamine neurons and hormones.
    Fuxe K; Schubert J; Hökfelt T; Jonsson G
    Adv Biochem Psychopharmacol; 1974; 10():67-74. PubMed ID: 4846547
    [No Abstract]   [Full Text] [Related]  

  • 39. Evidence for a central 5-hydroxytryptamine receptor stimulation by lysergic acid diethylamide.
    Andén NE; Corrodi H; Fuxe K; Hökfelt T
    Br J Pharmacol; 1968 Sep; 34(1):1-7. PubMed ID: 5302837
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neurotoxicity of hydroxylated tryptamines: structure-activity relationships. 1. Long-term effects on monoamine content and fluorescence morphology of central monoamine neurons.
    Baumgarten HG; Björklund A; Nobin A; Rosengren E; Schlossberger HG
    Acta Physiol Scand Suppl; 1975; 429():5-27. PubMed ID: 1064287
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.